4D Molecular Therapeutics revenue increased from $5.8 million in 2017 to $14.1 million in 2018, a (144.0%) increase.

Annual Revenue ($)

4D Molecular Therapeutics revenue was $14.13 m in FY, 2018 which is a (144.0%) year over year increase from the previous period.

FY, 2017FY, 2018
Revenue$5.79 m$14.13 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

4D Molecular Therapeutics revenue breakdown by business segment: 63.6% from Collaboration and Research Revenue (Related Parties) and 36.4% from Collaboration and Research Revenue

FY, 2018FY, 2017
Collaboration and Research Revenue (Related Parties)$8.99 m$2.61 m
Collaboration and Research Revenue$5.14 m$3.18 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu